You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2024

~ Buy the EXEM FOAM KIT (air polymer-type a) Drug Profile, 2024 PDF Report in the Report Store ~

EXEM FOAM KIT Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Exem Foam Kit, and what generic alternatives are available?

Exem Foam Kit is a drug marketed by Giskit and is included in one NDA. There are three patents protecting this drug.

This drug has six patent family members in six countries.

The generic ingredient in EXEM FOAM KIT is air polymer-type a. There are thirty-seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the air polymer-type a profile page.

DrugPatentWatch® Generic Entry Outlook for Exem Foam Kit

Exem Foam Kit was eligible for patent challenges on November 7, 2023.

Indicators of Generic Entry

< Available with Subscription >

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for EXEM FOAM KIT?
  • What are the global sales for EXEM FOAM KIT?
  • What is Average Wholesale Price for EXEM FOAM KIT?
Summary for EXEM FOAM KIT
International Patents:6
US Patents:3
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
DailyMed Link:EXEM FOAM KIT at DailyMed
Drug patent expirations by year for EXEM FOAM KIT

US Patents and Regulatory Information for EXEM FOAM KIT

EXEM FOAM KIT is protected by three US patents and one FDA Regulatory Exclusivity.

Patents protecting EXEM FOAM KIT

Composition and method for medical imaging of body cavities
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: USE IN SONOHYSTEROSALPINOGRAPHY TO ASSESS FALLOPIAN TUBE PATENCY

Composition and method for medical imaging of body cavities
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: USE IN SONOHYSTEROSALPINOGRAPHY TO ASSESS FALLOPIAN TUBE PATENCY

Composition and method for medical imaging of body cavities
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

FDA Regulatory Exclusivity protecting EXEM FOAM KIT

NEW CHEMICAL ENTITY
Exclusivity Expiration: ⤷  Sign Up

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Giskit EXEM FOAM KIT air polymer-type a FOAM;INTRAUTERINE 212279-001 Nov 7, 2019 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Giskit EXEM FOAM KIT air polymer-type a FOAM;INTRAUTERINE 212279-001 Nov 7, 2019 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Giskit EXEM FOAM KIT air polymer-type a FOAM;INTRAUTERINE 212279-001 Nov 7, 2019 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Giskit EXEM FOAM KIT air polymer-type a FOAM;INTRAUTERINE 212279-001 Nov 7, 2019 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for EXEM FOAM KIT

See the table below for patents covering EXEM FOAM KIT around the world.

Country Patent Number Title Estimated Expiration
Poland 2488211 ⤷  Sign Up
European Patent Office 2488211 Composition et procédé d'imagerie médicale de cavités corporelles (Composition and method for medical imaging of body cavities) ⤷  Sign Up
Denmark 2488211 ⤷  Sign Up
Spain 2529564 ⤷  Sign Up
World Intellectual Property Organization (WIPO) 2011046437 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.